Eam Investors, LLC Medpace Holdings, Inc. Transaction History

Eam Investors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$372.0 - $424.34 $536,424 - $611,898	-1,442 Reduced 17.29%	6,899 $2.84 Million
Q1 2024 May 13, 2024	SELL	$284.87 - $413.31 $1.16 Million - $1.69 Million	-4,087 Reduced 32.89%	8,341 $3.37 Million
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $1.45 Million - $2 Million	6,392 Added 105.9%	12,428 $3.81 Million
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $1.41 Million - $1.7 Million	6,036 New	6,036 $1.46 Million
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $1.59 Million - $2.24 Million	-23,378 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$61.71 - $101.95 $1.44 Million - $2.38 Million	23,378 New	23,378 $1.72 Million
Q4 2019 Feb 11, 2020	SELL	$70.08 - $84.64 $1.48 Million - $1.79 Million	-21,149 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.38 - $85.89 $1.32 Million - $1.82 Million	21,149 New	21,149 $1.78 Million
Q1 2019 May 13, 2019	SELL	$49.38 - $70.58 $1.43 Million - $2.04 Million	-28,911 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$46.97 - $63.98 $941,842 - $1.28 Million	-20,052 Reduced 40.95%	28,911 $1.53 Million
Q3 2018 Nov 08, 2018	BUY	$43.25 - $63.74 $2.12 Million - $3.12 Million	48,963 New	48,963 $2.93 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.